welbournes

/welbournes

About welbournes

This author has not yet filled in any details.
So far welbournes has created 363 blog entries.

National Patient Safety Alert: Discontinuation of Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup

National Patient Safety Alert: Discontinuation of Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup National Patient Safety Alert Reference Number: NatPSA/2024/011/DHSC Date issued: 21-Oct-2024 This NatPSA supersedes NatPSA/2024/008/DHSC This alert is for action by: All organisations involved in prescribing, dispensing and administering Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup. This is a safety critical [...]

The post National Patient Safety Alert: Discontinuation of Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup appeared first on Community Pharmacy England.

By |October 21st, 2024|Lexpos News|Comments Off on National Patient Safety Alert: Discontinuation of Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup

Medicine Supply Notification: NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens

Department of Health and Social Care (DHSC) has issued a medicine supply notification for NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens MSN/2024/103 Tier 2 – medium impact Date of issue: 16th October 2024 TO NOTE: This is the first of three MSNs covering discontinuations with Novo Nordisk insulin products (NovoRapid® FlexTouch®, [...]

The post Medicine Supply Notification: NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens appeared first on Community Pharmacy England.

By |October 16th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens

Medicine Supply Notification: NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens

Department of Health and Social Care (DHSC) has issued a medicine supply notification for NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens MSN/2024/103 Tier 2 – medium impact Date of issue: 16th October 2024 TO NOTE: This is the first of three MSNs covering discontinuations with Novo Nordisk insulin products (NovoRapid® FlexTouch®, [...]

The post Medicine Supply Notification: NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens appeared first on Community Pharmacy England.

By |October 16th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens

October 2024 Price Concessions 1st Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (15/10/2024) announced the following list of price concessions for October 2024: Drug Pack size Price concession Cefalexin 500mg capsules 21 £2.67 Chloramphenicol 0.5% eye drops 10 £2.90 Clarithromycin [...]

The post October 2024 Price Concessions 1st Update appeared first on Community Pharmacy England.

By |October 15th, 2024|Lexpos News|Comments Off on October 2024 Price Concessions 1st Update

MHRA Class 4 Medicines Defect Information: Linezolid 600 mg film-coated tablets (Sandoz Ltd)

MHRA Class 4 Medicines Defect Information: Linezolid 600 mg film-coated tablets (Sandoz Ltd) Drug alert number: EL (24)A/48 Date issued: 10 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Linezolid 600 mg film-coated tablets (Sandoz Ltd) Company name: Sandoz Ltd Product name: Linezolid 600 [...]

The post MHRA Class 4 Medicines Defect Information: Linezolid 600 mg film-coated tablets (Sandoz Ltd) appeared first on Community Pharmacy England.

By |October 10th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Linezolid 600 mg film-coated tablets (Sandoz Ltd)